Orthogate Subspecialty Journal Scan: Knee Surgery & Reconstruction

Curated critical appraisals of recent high-impact clinical trials and systematic evidence across knee arthroplasty and cartilage restoration, evaluating robotic arm assistance in unicompartmental knee arthroplasty, intraosseous analgesia in primary total knee arthroplasty, and donor-recipient sex matching in osteochondral allograft transplantation.

Featured Knee Studies This Week (September 2026)
Knee Arthroplasty

1. A Prospective Double-Blinded Randomized Controlled Trial Comparing Conventional Jig-Based Versus Robotic Arm-Assisted Medial Unicompartmental Knee Arthroplasty

Authors: Kayani B, Fontalis A, Tahmassebi J, Konan S, Plastow R et al. | Journal: The Bone & Joint Journal (Sep 2026) | View Source / DOI

Situation

Medial unicompartmental knee arthroplasty (UKA) offers faster recovery, improved kinematics, and bone conservation compared to total knee arthroplasty (TKA), but historical registry data show higher revision rates often tied to component malposition. This study evaluates whether robotic arm-assisted UKA (RO UKA) improves component positioning accuracy, early postoperative recovery, inpatient narcotic requirements, and two-year functional outcomes compared to conventional jig-based UKA with navigational control (CO UKA) in patients with isolated medial compartment osteoarthritis.

Background

The precision of component alignment and soft tissue balance in medial UKA is notoriously unforgiving: minor coronal or sagittal malalignment can accelerate wear or stress transfer to the retained lateral and patellofemoral compartments. While robotic arm technology provides CT-based preoperative planning and dynamic haptic boundary control, prospective double-blind Level-I randomized evidence evaluating both perioperative metrics and mid-term patient-reported outcome measures has been limited.

Assessment & Findings
  • Design & Cohort: Prospective, double-blinded randomized controlled trial enrolling 107 patients with symptomatic isolated medial compartment osteoarthritis randomized to either conventional jig-based UKA (CO UKA, n = 52) or robotic arm-assisted UKA (RO UKA, n = 55). Both treatment groups received CT-based surgical planning, underwent a standardized medial parapatellar approach, and followed an identical postoperative rehabilitation pathway, with predefined clinical and functional assessments evaluated through two years postoperatively.
  • Component Accuracy & Early Recovery: RO UKA achieved statistically superior accuracy in executing planned femoral (p < 0.001) and tibial (p < 0.001) component positions compared to CO UKA. In the immediate postoperative phase, RO UKA was associated with significantly reduced inpatient pain scores (p < 0.001), lower inpatient opioid analgesia consumption (p = 0.008), and a significantly shorter length of hospital stay (p = 0.004).
  • PROMs & Joint Awareness: At two-year follow-up, general knee outcome instruments showed equivalent improvements between groups, with no statistically significant differences in the Oxford Knee Score (p = 0.299), Knee Injury and Osteoarthritis Outcome Score (KOOS, p = 0.261), or WOMAC Index (p = 0.281). However, RO UKA demonstrated statistically superior Forgotten Joint Scores (FJS) at both six months (p = 0.002) and two years (p = 0.021). Notably, patient recruitment slowed as patient preference for robotic surgery increased and surgeon equipoise diminished.
Recommendation & Practice Takeaway

Clinical Pearl: Robotic arm assistance in medial UKA significantly enhances bone cut precision, reduces inpatient opioid requirements, shortens hospitalization, and delivers superior joint awareness (higher Forgotten Joint Scores) through two years. While general joint scores (OKS, KOOS, WOMAC) reach equivalent ceilings at mid-term follow-up, the primary clinical dividends of robotic execution are early soft tissue preservation and elimination of implant positioning outliers. Surgeons should leverage robotic precision to optimize outpatient arthroplasty pathways while maintaining disciplined patient selection criteria.

Knee Arthroplasty & Analgesia

2. Effectiveness of Intraosseous Morphine for Pain Control in Total Knee Arthroplasty: A Double-Blinded, Randomized Trial

Authors: Pekas D, Adrados M, Lee M, Lee Y, Burks W et al. | Journal: The Journal of Bone and Joint Surgery (Am) (Aug 2026) | View Source / DOI

Situation

Postoperative pain management is a critical determinant of early mobilization, rapid recovery, and patient satisfaction following elective total knee arthroplasty (TKA). Despite advanced multimodal analgesia regimens, severe early pain remains challenging. This double-blinded RCT investigated whether an intraoperative intraosseous (IO) regional injection of morphine provides superior analgesia and reduces narcotic consumption over the first two weeks postoperatively.

Background

Intraosseous administration of regional prophylactic antibiotics under tourniquet control is widely utilized in primary TKA to achieve high local bone and soft tissue concentrations. Extending this delivery technique to analgesics, proponents hypothesized that intramedullary morphine would bind peripheral opioid receptors in subchondral bone and periarticular tissues, providing prolonged local pain relief without the adverse systemic effects of systemic narcotics. High-level trial validation has been absent.

Assessment & Findings
  • Design & Cohort: Prospective, double-blinded, randomized controlled trial enrolling 100 elective primary TKA patients, with 88 completing the final analysis (mean age: 69.1 +/- 9.0 years, range 46 to 89; 52.3% female [n = 46]; 89.8% White [n = 79]). All patients received standardized spinal anesthesia, intravenous sedation, and an intraoperative surgeon-administered adductor canal block.
  • Interventions & Methodology: Under tourniquet occlusion, the experimental cohort received an intraoperative IO injection containing 10 mg morphine plus 500 mg vancomycin diluted in 110 mL normal saline. The control cohort received an identical IO injection of 500 mg vancomycin in 110 mL saline without morphine. Patients completed six automated daily text-message surveys (three morning, three evening) for 14 days postoperatively to record visual pain scores, oral morphine milligram equivalent (MME) consumption, and nausea or vomiting events. Outcomes were analyzed via linear mixed-effects (LME) models.
  • Analgesic & Opioid Endpoints: The LME model revealed zero statistically significant differences between cohorts in daily pain scores across any time point over the 14-day postoperative period (p = 0.969). Daily MME consumption was likewise indistinguishable between groups (p = 0.377). No significant differences were observed in cumulative total MME consumption or weekly MME totals (p >= 0.878), and post-anesthesia care unit (PACU) pain scores and PACU opioid requirements were identical.
Recommendation & Practice Takeaway

Clinical Pearl: Intraosseous morphine provides no additional pain reduction or opioid-sparing benefit compared to placebo in primary total knee arthroplasty managed with modern multimodal analgesia. Surgeons utilizing intraosseous prophylactic vancomycin infusions should not add morphine to the regional infusate, as it adds pharmaceutical preparation overhead and potential medication error risks with zero clinical return. Standardize on validated multimodal pathways: motor-sparing peripheral nerve blocks (adductor canal and IPACK), robust periarticular local infiltration analgesia (LIA), scheduled non-opioid oral agents, and cryotherapy.

Sports Medicine & Cartilage Restoration

3. Sex Mismatch Does Not Affect Outcomes or Graft Survival After Osteochondral Allograft Transplantation of the Knee: A Systematic Review

Authors: Mowers C, Jackson G, McKinley M, Hus A, Childers J et al. | Journal: Arthroscopy: The Journal of Arthroscopic & Related Surgery (Sep 2026) | View Source / DOI

Situation

Fresh osteochondral allograft transplantation (OCAT) is an established joint-preservation intervention for large, full-thickness chondral and osteochondral defects in the knee. Donor allograft availability is severely constrained by sizing matching and tissue shelf-life. This PRISMA systematic review examined whether donor-recipient sex mismatch negatively affects graft survivorship, reoperation rates, or patient-reported outcome measures (PROMs).

Background

Fresh allografts contain living, metabolically active donor chondrocytes embedded within an avascular, immunoprivileged extracellular matrix alongside a subchondral bone plug. Prior hypotheses suggested sex mismatch (particularly male donor into female recipient) might impair osseous integration or accelerate cartilage degeneration due to minor histocompatibility disparities or subtle anatomical curvature discrepancies. Stringent sex-matching criteria prolong patient waiting lists, increasing the risk of lesion progression and secondary osteoarthritis.

Assessment & Findings
  • Design & Search Scope: Systematic review conducted in accordance with PRISMA 2020 guidelines, searching PubMed, Embase, and Scopus through March 2025. Included studies evaluated Level I through IV comparative evidence assessing sex-matched versus sex-mismatched OCAT for knee cartilage defects with a minimum of two years of clinical follow-up. Methodological quality was evaluated using the Methodological Index for Non-Randomized Studies (MINORS).
  • Included Cohort & Techniques: Four Level III or IV comparative studies met all eligibility criteria, comprising 973 patients: 613 received sex-matched allografts and 360 received sex-mismatched grafts. Follow-up ranged from 3.3 to 5.4 years across studies. All investigations utilized fresh, press-fit osteochondral allograft dowel or shell configurations.
  • Survivorship & Complications: Three of the four included studies found no statistically significant differences in graft failure, reoperation rates, or functional PROMs between sex-matched and sex-mismatched cohorts. One single study noted a higher failure rate in sex-mismatched transplants (21.2% vs 6.9%, p = 0.02), primarily driven by male-to-female grafts; however, sex mismatch was not an independent predictor of failure across the broader literature. Across all cohorts, failure rates ranged from 5.2% to 21.2%, with bipolar graft reconstruction (opposing femoral and tibial lesions) identified as the most reliable predictor of graft failure.
Recommendation & Practice Takeaway

Clinical Pearl: Routine donor-recipient sex matching is unnecessary in osteochondral allograft transplantation of the knee. Surgeons and tissue banks should prioritize morphological match, condylar radius of curvature, and defect depth rather than donor sex, thereby dramatically expanding donor allograft availability and reducing wait times for young active patients. Clinical risk stratification should focus instead on lesion morphology: while isolated condylar allografts yield reliable mid-term survivorship regardless of sex pairing, bipolar grafts carry substantial failure risks and necessitate cautious preoperative counseling.

Orthogate Journal Scan: Knee Surgery & Reconstruction is curated weekly by ORION (Orthopaedic Research, Intelligence & Operations Navigator) for orthopaedic attendings, fellows, and residents under the clinical direction of Christian Veillette, MD, MSc, FRCSC.